Concise, asymmetric, stereocontrolled total synthesis of stephacidins A, B and notoamide B

Journal of the American Chemical Society

Volumn 129, Issue 19, 2007, Pages 6336-6342

  Artman III, Gerald D ^a   Grubbs, Alan W ^a   Williams, Robert M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIZATION; ESTERS; FUNCTIONAL GROUPS; FUNGI; METABOLITES; MICROWAVE HEATING; SYNTHESIS (CHEMICAL);

BRIDGED BICYCLIC RING SYSTEMS; FACILE SYNTHESIS; PYRANOINDOLE RING SYSTEMS; STEPHACIDINS;

AMIDES;

ALKALOID; ESTER DERIVATIVE; FUNCTIONAL GROUP; INDOLE;

ARTICLE; ASYMMETRIC SYNTHESIS; CYCLIZATION; FUNGAL METABOLISM; METABOLITE; MICROWAVE COOKING; REACTION TIME; RING CLOSING METATHESIS;

CYCLIZATION; INDOLE ALKALOIDS; MOLECULAR STRUCTURE;

EID: 34249112804     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja070259i     Document Type: Article

References (48)

1. (a) Qian-Cutrone, J.; Haung, S.; Shu, Y.-Z.; Vyas, D.; Fairchild, C.; Menendez, A.; Krampitz, K.; Dalterio, R.; Klohr, S. E.; Gao, Q. J. Am. Chem. Soc. 2002, 124, 14556-14557.
2. (b) Qian-Cutrone, J.; Krampitz, K. D.; Shu, Y.-Z.; Chang, L. P. U.S. Patent 6,291,461, 2001.
3. For a short review concerning the proposed mechanism of dimerization, see: Nussbaum, F. Angew. Chem., Int. Ed. 2003, 42, 2068-3071.
4. Fenical, W.; Jensen, P.; Cheng, X. C. U.S. Patent 6,066,635, 2000; Chem. Abstr. 2000, 132, 346709.
5. (a) Baran, P. S.; Guerrero, C. A.; Ambhaikar, N. B.; Hafensteiner, B. J. Angew. Chem., Int. Ed. 2005, 44, 606-609.
6. (b) Baran, P. S.; Guerrero, C. A.; Ambhaikar, N. B.; Hafensteiner, B. J. Angew. Chem., Int. Ed. 2005, 44, 3892-3895.
7. Herzon, S. B.; Myers, A. G. J. Am. Chem. Soc. 2005, 127, 5342-5344.
8. For a preliminary account of Myers' work, see: Myers, A. G.; Herzon, S. B. J. Am. Chem. Soc. 2003, 125, 12080-12081.
9. Myers, A. G.; Herzon, S. B.; Wulff, J. E.; Siegrist, R.; Svenda, J.; Zajac, M. A. WO Patent 2006102097, 2006.
10. For a full account of experiments conducted by the Baran, laboratories towards these alkaloids, see: Baran, P. S.; Hafensteiner, B. D.; Ambhaikar, N. B.; Guerrero, C. A.; Gallagher, J. D. J. Am. Chem. Soc. 2006, 128, 8678-8693.
11. For reviews of our previous synthetic and biosynthetic work concerning this class of alkaloids, see: (a) Williams, R. M.; Cox, R. J. Acc. Chem. Res. 2003, 36, 127-139.
12. (b) Williams, R. M. Chem. Pharm. Bull. 2002, 50, 711-740.
13. Kato, H.; Yoshida, T.; Tokue, T.; Nojiri, Y.; Hirota, H.; Ohta, T.; Williams, R. M.; Tsukamoto, S. Angew. Chem., Int. Ed. 2006, 46, 2254-2256.
14. For recent biomimetic total syntheses of notoamides B, C, D and stephacidin A from our laboratory, see: (a) Grubbs, A. W.; Artman, G. D.; Tsukamoto, T.; Williams, R. M. Angew. Chem., Int. Ed. 2006, 46, 2257-2261.
15. (b) Grubbs, A. W.; Greshock, T. J.; Tsukamoto, S.; Williams, R. M. Angew. Chem., Int. Ed. 2006, 46, 2262-2265.
16. Fuchser, J. Ph.D. Dissertation, University of Göttingen, 1995.
17. For preliminary studies towards the synthesis of the stephacidins using a biomimetic approach, see: Adams, L. A.; Gray, C. R.; Williams, R. M. Tetrahedron Lett. 2004, 45, 4489-4493.
18. (a) Williams, R. M.; Glinka, T. Tetrahedron Lett. 1986, 27, 3581-3584.
19. (b) Williams, R. M.; Glinka, T.; Kwast, E. J. Am. Chem. Soc. 1988, 110, 5927-5929.
20. (c) Williams, R. M.; Glinka, T.; Kwast, E.; Coffman, H.; Stille, J. K. J. Am. Chem. Soc. 1990, 112, 808-821.
21. Williams, R. M.; Cao, J.; Tsujishima, H. J. Am. Chem. Soc. 2003, 125, 12172-12178.
22. (a) Cushing, T. D.; Sanz-Cervera, J. F.; Williams, R. M. J. Am. Chem. Soc. 1993, 115, 9323-9324.
23. (b) Cushing, T. D.; Sanz-Cervera, J. F.; Williams, R. M. J. Am. Chem. Soc. 1996, 118, 557-579.
24. (a) Seebach, D.; Boes, M.; Naef, R.; Schweizer, W. B. J. Am. Chem. Soc. 1983, 105, 5390.
25. (b) Beck, A. K.; Blank, S.; Job, K.; Seebach, D.; Sommerfield, T. Org. Synth. 1995, 72, 62.
26. Wang, H.; Germanas, J. P. Synlett 1999, 33-36.
27. (a) Hoffman, T.; Lanig, H.; Waibel, R.; Gmeiner, P. Agnew Chem., Int. Ed. 2001, 40, 3361-3365.
28. (b) Bittermann, H.; Einsiedel, J.; Hübner, H.; Gmeiner, P. J. Med. Chem. 2004, 47, 5587-5590.
29. (c) Bittermann, H.; Gmeiner, P. J. Org. Chem. 2006, 71, 97-102.
30. Artman, G. D.; Williams, R. M. Org. Synth., submitted for publication 2007.
31. Grubbs, A. W.; Artman, G. D.; Williams, R. M. Tetrahedron Lett. 2005, 46, 9013-9016.
32. Tisdale, E. J.; Vong, B. G.; Li, H.; Kim, S. H.; Chowdhury, C.; Theodorakis, E. A. Tetrahedron 2003, 59, 6873-6887.
33. For reviews concerning microwave-assisted organic synthesis, see: (a) Lidstrom, P.; Tierney, J.; Wathey, B.; Westman, J. Tetrahedron 2001, 57, 9225-9283.
34. (b) Bose, A. K.; Manhas, M. S.; Ganguly, S. N.; Sharma, A. H.; Banik, B. K. Synthesis 2002, 1578-1591.
35. (c) Kuhnert, N. Angew. Chem., Int. Ed. 2002, 41, 1863-1866.
36. (d) The thermal lability of the N-t-Boc protecting group has documented, see: Krakowiak, K. E.; Bradshaw, J. S. Synth. Commun. 1996, 26, 3999-4004.
37. (a) Somei, M.; Karasawa, Y.; Kaneko, C. Heterocycles 1981, 16, 941-949.
38. (b) Kametani, T.; Kanaya, N.; Ihara, M. J. Chem. Soc., Perkin Trans. 1 1981, 959-963.
39. For a general review on olefin cross-metathesis, see: Chatterjee, A. K.; Choi, T.-L.; Sanders, D. P.; Grubbs, R. H. J. Am. Chem. Soc. 2003, 125, 11360-11370.
40. For recent total syntheses that employ olefin cross-metathesis, see: (a) Trost, B. M.; Thiel, O. R.; Tsui, H.-C. J. Am. Chem. Soc. 2003, 125, 13155-13164.
41. (b) Vyvyan, J. R.; Loitz, C.; Looper, R. E.; Mattingly, C. S.; Peterson, E. A.; Staben, S. T. J. Org. Chem. 2004, 69, 2461-2468.
42. Liu, B.; Das, S. K.; Roy, R. Org. Lett. 2002, 4, 2723-2726.
43. For microwave olefin cross-metathesis, see: Bargiggia, F. C.; Murray, W. V. J. Org. Chem. 2005, 70, 9636-9639.
44. Trost, B. M.; Fortunak, J. M. D. Organometallics 1982, 1, 7-13.
45. Similar results were observed by the Baran group during their synthetic efforts towards stephacidin A. Please see their full account listed in ref 8 for exact conditions explored.
46. Note added in revision: (a) For a biomimetic synthesis of the related alkaloid d,l-marcfotine C, see: Greshock, T. J.; Grubbs, A. W.; Williams, R. M. Tetrahedron 2007, DOI: 10.1016/j.tet.2007.03.016.
47. (b) For a recent synthesis of d,l-marcfortine B. see: Trost, B. M.; Cramer, N.; Bernsmann, H. J. Am. Chem. Soc. 2007, 129, 3086-3087.
48. Note added in proof: Myers, et al., recently reported that stephacidin B converts to avrainvillamide in cell culture with avrainvillamide being the biologically active species: Wulff, J. E.; Herzon, S. B.; Siegrist, R.; Myers, A. G. J. Am. Chem. Soc. 2007, 129, 4898-4899.